Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-09 Purchase |
2021-06-09 7:00 pm |
Sonnet BioTherapeutics Holdings Inc. | SONN | Kenney Richard T Chief Medical Officer |
15,000 | $1.54 | $23,100 | 50,000 (Direct) |
View |
2021-06-09 Purchase |
2021-06-09 6:59 pm |
Sonnet BioTherapeutics Holdings Inc. | SONN | Mohan Pankaj Chairman, President and CEO |
32,000 | $1.5494 | $49,580 | 1,292,963 (Indirect Direct) |
View |
2021-05-19 Purchase |
2021-05-20 07:52 am |
Sonnet BioTherapeutics Holdings Inc. | SONN | Kenney Richard T Chief Medical Officer |
10,000 | $1.55 | $15,500 | 35,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-12-14 Option Award |
2022-12-22 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | McNeill Lori Director |
3,770 | $0 | 3,770 (Direct) |
View |
2022-12-14 Option Award |
2022-12-22 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Kenney Richard T Chief Medical Officer |
14,627 | $0 | 64,627 (Direct) |
View |
2022-12-14 Option Award |
2022-12-22 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Dyrness Albert D. Director |
3,770 | $0 | 30,893 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Dexter Susan Chief Technical Officer |
63,104 | $0 | 126,572 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Griffith Donald J. Director |
15,000 | $0 | 106,186 (Direct) |
View |
2022-04-08 Tax Withholding |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Griffith Donald J. Director |
4,507 | $0.3673 | 106,186 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Rao Raghu Director |
14,152 | $0 | 22,370 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
80,034 | $0 | 304,101 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Mohan Pankaj Chairman, President and CEO |
320,135 | $0 | 1,613,098 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
66,951 | $0 | 145,165 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Dyrness Albert D. Director |
14,152 | $0 | 27,123 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Bhatt Nailesh Director |
14,152 | $0 | 27,485 (Direct) |
View |
2021-05-25 Tax Withholding |
2021-05-28 4:00 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
14,004 | $1.51 | 224,067 (Direct) |
View |
2021-05-25 Tax Withholding |
2021-05-28 4:00 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Griffith Donald J. Director |
4,235 | $1.51 | 95,693 (Direct) |
View |
2021-05-25 Tax Withholding |
2021-05-28 4:00 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Dexter Susan Chief Technical Officer |
10,145 | $1.51 | 63,468 (Direct) |
View |
2021-03-25 Option Award |
2021-04-01 4:32 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Kenney Richard T Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |